Microcin 7 is a small peptide produced and excreted to the culture medium by stationary-phase Escherichia coli cells harboring the pMccC7 plasmid (formerly named pRYC7). This peptide inhibited the growth of the enterobacteria phylogenetically closer to E. coli, apparently by blocking protein biosynthesis. The molecule was degraded with trypsin, and the resulting fragments were purified and sequenced. The results show that microcin 7 is a linear heptapeptide blocked at both ends.
Microcins are dialyzable (i.e., low-molecular-weight) antibacterial agents originally found in bacterial isolates from the feces of newborn infants (1) . Most of the microcins seem to be peptides, and, unlike the classical bacteriocins, they are not inducible by agents that trigger the SOS system for DNA repair (for a review, see reference 4).
The synthesis of microcins is not lethal for the producer cells, and it requires the presence of plasmids specific for each type of microcin (3, 21) . Five such microcin types have been characterized so far. In each case, the microcinogenic plasmid is also implicated in the expression of the immunity that the producer strains show to their own microcins, even when the microcins are added exogenously (4) .
Free microcin-like substances have been found in fecal samples, and microcin-producing strains tend to predominate in patients with jejunal bacterial overgrowth. Furthermore, the colonization ability of Escherichia coli K-12 given orally to Swiss mice is clearly enhanced by microcinogenic plasmids (4) . These results, together with the high diffusibility and in some cases the resistance of microcins to intestinal proteases, have led us to propose a role for these compounds in the displacements of bacterial populations that take place in the intestine under both normal and pathological conditions (2) . Bacteriocins are no longer thought to play a role in such ecological successions (15) , but as we mentioned above, microcins do not look like classical bacteriocins. As a matter of fact, they share properties with both bacteriocins and the secondary-metabolism antibiotics.
These peculiar features of microcins and their presence in the human intestinal ecosystem drew our attention to these substances, and we chose microcin 7 (or C7 according to the last proposals [4] ) for further studies. Since there were only scarce and indirect data on the chemical structure of microcins, we undertook the purification and analysis of microcin 7. The molecule was purified from the supematants of stationary cultures of E. coli RYC25 and was found to contain seven different amino acids at the most, which accounted for the apparent molecular weight as estimated by gel filtration chromatography (11) .
In the present work we report the amino acid sequence of the peptide (hence the first structural information on a microcin), the spectrum of its antimicrobial activity, and the first data on its mode of action.
MATERIALS AND METHODS
Trypsin treated with diphenylcarbamyl chloride, carboxypeptidase Y, phenylthiohydantoin amino acids, and Polybrene were purchased from Sigma Chemical Co., St. Louis, Mo. Carboxypeptidases A and B and aminopeptidase M were from E. Merck, Darmstadt, Federal Republic of Germany. High-pressure liquid chromatography (HPLC) solvents were of research standard, American Chemical Society quality from Carlo Erba, Milan, Italy. Water was deionized and distilled in glass over potassium permanganate. The reagents and solvents for the sequencer and amino acid analyzer were from Beckman Instruments Espafia, Madrid, Spain. L-Methionyl-L-arginine was from Serva, Heidelberg, Federal Republic of Germany, and the radioactive compounds were from Amersham Corp., Arlington Heights, Ill. All other chemicals were analytical grade products commercially available.
All bacterial strains used were from the collection of the Servicio de Microbiologia, Centro Ram6n y Cajal, Madrid, Spain.
Tryptic digestions. Microcin 7 was obtained and purified by HPLC as described previously (11) . The lyophilized peptide was dissolved in 0.4 M ammonium bicarbonate (pH 7.6, 0.5 nmol/,ul) and incubated with trypsin at 37°C (enzyme/substrate ratio, 1 ,ug/100 nmol). The reaction was stopped at the desired time by the addition of an equal volume of 0.2% trifluoracetic acid and lyophilization of the digestion mixture.
Carboxypeptidase digestions. Tryptic peptides (3 to 5 nmol) were digested with carboxypeptidases under the following conditions: (i) 4 GARCIA-BUSTOS, PEZZI, AND MENDEZ pH 7.0. The digestions were carried out at 37°C, and they were stopped at the desired times by lyophilization. The products were analyzed for amino acids as described above.
Amino acid analyses. The samples were hydrolyzed in evacuated and sealed glass tubes at 110°C for 18 h with 200 ,ul of 5.7 N HCI containing 0.02% (vol/vol) 2-mercaptoethanol. The analyses were performed in a Beckman 121-M analyzer equipped with a 126 Data System Integrator.
Sequencing procedures. The selected tryptic peptides were sequenced by the manual Edman procedure (9) . The method of Edman and Begg (8) for automatic sequencing was also followed, with a model 890-D Beckman sequencer and the standard Beckman 0.1 M Quadrol program. To reduce peptide washout, 3 ml of Polybrene was added when the sample was applied to the cup (26) . Amino acidic residues were identified in the amino acid analyzer, after back hydrolysis of the corresponding aniliniothiazolinone at 150°C for 4 h with 5.7 N HCl containing 0.1% (wt/vol) SnCl (18) . Amide assignments were made by converting a fraction (70%) of the thiazolinone obtained in a given step to phenylthiohydantoin (13) . The phenylthiohydantoin amino acids were identified by thin-layer chromatography on cellulose plates with an incorporated fluorescent dye (Merck). Elution was performed in the same direction with a first system composed of n-heptane-propionic acid-1,2-dichloroethane (70:20:50, vol/vol/vol) and a second system composed of chloroformmethanol (87:13, vol/vol). The spots were visualized by fluorescence quenching at 254 nm.
HPLC. Microcin 7 and its tryptic peptides were purified with an HPLC system composed of M-6000A and M-45 pumps, an M-660 solvent delivery system, and an M-441 UV multiwavelength absorbance detector, all from Waters Associates, Milford, Mass. Samples were dissolved in 0.1% (vol/vol) trifluoroacetic acid and applied either to a ,uBondapak-C18 column (0.4 by 30 cm; 10-,um mean particle size) from Waters or to a Lichrosorb RP-18 column (0.4 by 25 cm; 5-,um mean particle size) from Merck. In both cases, a guard column (270-,u volume) packed with Bondapak-C18-Porasil B (Waters) was used. All chromatographic runs were done at room temperature with a flow rate of 1 ml/min. Detection was carried out at 206 or 214 nm.
Acylation ofL-Met-L-Arg. The commercial dipeptide L-Met-L-Arg was formylated essentially as described previously (24) , but with the following modifications. A 10-mg amount of the dipeptide in 60 RI of 98% formic acid was treated at room temperature with a total of 20 RI of acetic anhydride, distributed over five additions in the course of 1 h. After one additional hour at room temperature, the mixture was lyophilized, and the formylated dipeptide was purified by HPLC.
The N-acetyl derivative was prepared as described elsewhere (17) , and the reaction products were also fractionated by HPLC.
Incorporation of labeled precursors into macromolecules.
E. coli GS7T1 was used as the microcin-susceptible bacteria in the labeling experiments. This strain is a spontaneous thymine auxotroph isolated by us using trimethoprim (19) to select it from E. coli GS7 (F-araD139 AlacU169 relA rpsL thi malE7::TnS) (12) , which is the parental strain of the strain used as microcin producer (11) . Strain GS7T1 was routinely grown at 37°C in minimal medium M9 (19) supplemented (per milliliter) with thiamine (10 ,ug), L-leucine (10 ,ug) , (20 ,ug) , thymine (50 pLg), streptomycin (100 ,ug) and kanamycin (20 ,ug 
To measure the incorporation of label into DNA, RNA, and proteins, the appropriate precursors were added at a final concentration (per milliliter) of 10 ,uCi, 0.5 ,uCi, and 0.5 ,uCi, respectively. Duplicate 200-,u samples were taken at regular intervals and deposited in tubes containing 3 ml of 5% trichloroacetic acid (TCA) and kept in an ice bath. The tubes with samples from the culture labeled with leucine were boiled for 15 min to hydrolyze any charged tRNAs. In every case, the precipitated material was collected on Whatman GF/C filters which were washed with 30 ml of ice-cold 5% TCA, dried, placed into a scintillation fluid composed of 5.5 g of Permablend (Packard Instrument Co., Inc., Rockville, Md.) per liter of toluene, and counted in a Beckman LS-2800 scintillation counter.
Tritiated diaminopimelic acid at a final concentration of 10 jig and 10 ,uCi/ml was used to label cell walls. In this case, each 200-pI sample was deposited in a tube containing 3 ml of 4% sodium dodecyl sulfate and kept in a boiling-water bath for 30 min. After being cooled, the insoluble material was collected on HAWP filters (0.45-,um pore size; Millipore Corp., Bedford, Mass.), washed with 30 ml of distilled water, and counted as described above.
The incorporation rate of leucine and uridine during 2-min pulses was measured essentially under the same conditions, except for the volume of the cultures, which was scaled up 10 times. At the desired times, duplicate 0.9-ml samples from the control and microcin-treated cultures were transferred to tubes containing 0.1 ml of prewarmed growth medium, with either 20 ,uCi of [14C]leucine, 5 ,uCi of tritiated leucine, or 3 jCi of tritiated uridine per ml. After incubation at 37°C for 2 min, 1 ml of ice-cold 10% TCA was added, and those tubes labeled with leucine were boiled for 15 min. The precipitates were collected on Whatman GF/C filters and washed and counted as described above.
All the results were collected for the number of viable cells present at each time.
Transport of leucine. 
RESULTS
Tryptic peptides. Microcin 7 was purified by HPLC as described previously (11) , until it behaved homogeneously in several HPLC systems (Fig. 1) . The amino acid composition of the sample used in this work is shown in Table 1 . This peptide does not react with ninhydrin, indicating that its amino end is blocked and therefore that it cannot be sequenced by the Edman procedure. The presence of arginine in its amino acid composition (Table 1 ) and the observed inactivation of the antimicrobial activity upon treatment with trypsin (11) suggested that the protease could be used to generate fragments amenable to sequential degradation. The purified microcin was digested overnight with trypsin as described above, and the products were fractionated by HPLC (Fig. 2) . Five amino acid-containing peaks were obtained and were termed Ta, Tb, Tc, Td, and Te. The amino acid composition of these peaks is given in Table 1 . The major peptides, Tb and Td, accounted for the composition of the complete microcin molecule. Three additional peptides with low yield were also obtained, i.e., Ta, with the same composition as Tb, and Tc and Te, which at the level of amino acid composition are identical to Td.
Different microcin preparations yielded different Ta/Tb ratios, but Tb was always the major fraction. The ratio of Td to the other peptides with the same composition, Tc and Te, did not vary with the microcin preparation but was dependent on the digestion time. The kinetics of appearance of the different tryptic fragments during the first 6 h of hydrolysis showed that Ta, Tb, and Td appeared concomitantly with the disappearance of the microcin 7 peak (Fig. 3) , whereas the height of the Tc And Te peaks increased gradually with the incubation time.
Peptide Tb must come from the amino end of the molecule, since it has all the arginine present and, like the native microcin molecule, was not stained by ninhydrin on thin layers. The sequence of Tb was further investigated by digestion with carboxypeptidase B. The analysis of the digestion products showed that arginine was the only ninhydrin-positive product present and that it was obtained with a yield comparable to that obtained after acid hydrolysis of the peptide. This result implies that the sequence of Tb is X-Met-Arg, where X represents an acid-labile group which blocks the amino terminus of microcin 7. The same results were obtained with the minority peptide Ta. Additionally, we isolated from some microcin preparations a dipeptide which, upon treatment with carboxypeptidase B, yielded equimolar amounts of arginine and methionine sulfoxide, indicating that during the experimental manipulations, some amino termini had been unblocked and the methionine residues Were oxidized in some molecules. To investigate the nature of the amino-blocking group, we The tryptic peptides coming from the carboxy-terminal end of the microcin molecule, namely, Tc, Td, and Te, had a free amino termius, and they were subjected to manual and automatic Edman degradation (Fig. 4) . The composition of the amino-terminal end of Td was confirmed by aminopeptidase M digestion ( (Table 3) .
We have estimated the MIC of microcin 7 in different media against E. coli GS7 and its derivative E. coli RYC25, which carries the plasmid that codes for the expression of this particular microcin (11) . In minimal (M9), C.L.E.D., and Mueller-Hinton media, strain GS7 was inhibited by 0.4, 1, and 3 nmol/ml, respectively, whereas its microcinogenic derivative could grow in the presence of as much as 32 nmol of the peptide per ml in all media.
Mode of action of microcin 7. We have investigated the effect of microcin 7 on the biosynthesis of mnacromolecules in E. coli GS7T1 at its MIC, a concentration just high enough to stop the growth of logarithmic-phase cells (Fig. 5) . At this concentration the cells retain their viability in the presence of the microcin for at least 8 h (data not shown).
Under these conditions, the incorporation of either thymine or uridine into material insoluble in 5% TCA was not affected ( Fig. 6 and 7 ). The incorporation of diaminopimelic acid into material insoluble in boiling 4% sodium dodecyl sulfate was apparently stimulated by microcin 7 (Fig. 6) , whereas the incorporation of leucine into macromolecules was inhibited after a few minutes (Fig. 7) . The lag was reduced when the number of cells present in the assay was lowered or when the concentration of the antibacterial agent was raised, suggesting that the lag represented the time needed by the peptide to reach an intracellular concentration high enough to produce a noticeable effect. To increase the sensitivity of the assay, we measured the incorporation rate, rather than the total accumulation, of labeled leucine in the macromolecules of exponentially growing cells treated with microcin 7. The incorporation of uridine wa,s measured at the same time in the same cultures. We found that although RNA synthesis proceeded unaffected, the rate of protein synthesis decreased markedly after the first 10 min of treatment (Fig. 7) . The possibility that the microcin might be interfering with the transport of the precursor used to estimate protein biosynthesis was also tested (Fig. 8) . The transport of leucine was measured at twice the concentration (per cell) of microcin 7 used in the incorporation experiments. After 20 min in the presence of microcin, the treated cells transported leucine at the same rate as the controls, and after the first 2 min of the assay, both cultures retained stable, comparable levels of intracellular leucine, at least for 15 min more (data not shown).
DISCUSSION
When a sample of microcin 7 previously found to be homogeneous by HPLC is digested with trypsin, the molecule is split mainly into an amino-terminal dipeptide (Tb) and a carboxy-terminal pentapeptide (Td). A variable but minor amount of another dipeptide (Ta), with the same composition as Tb, is also obtained ( Table 1 ). The finding of methionine sulfoxide in a microcin preparation suggests that the purified native peptide, when kept in aqueous solutions for long times, may be partially oxidized on its N-terminal methionine to the corresponding sulfoxide, as has been found in other peptides (22, 25) . The oxidized amino-terminal ends would correspond to the dipeptide Ta, since Ta is the fragment that appears in smaller amounts when sample 5 . Effect of microcin 7 on the growth of E. coli GS7T1. Two 6-ml cultures of E. coli GS7T1, growing exponentially in the minimal medium described in the text, were incubated in 125-ml Erlenmeyer flasks at 37°C with vigorous agitation. At zero time, the cell density was 1.8 x 108 CFUIml, and then one of the cultures received 0.4 nmol of microcin 7 per ml (0) and the other culture was kept as a control (0). The growth of both cultures was followed by measuring OD6w.
handling is minimized and that has the shorter retention time in reverse-phase HPLC (Fig. 2) .
The peptide from the carboxy-terminal side of microcin 7, Td, if left for long times in the tryptic digestion mixture, undergoes secondary modifications that yield two other molecular species, Tc and Te, with the same amino acid sequence but separable by HPLC (Fig. 3 and 4) . The simplest explanation for this change is that the Asx residues are undergoing a,,B-rearrangements, which are known to occur easily in small peptides (6, 20, 23) . Such a change would also explain the sharp drop in yield observed at the asparagine residue during sequencing (Fig. 4) and the blockade of aminopeptidase action at the same point under some conditions (Table 2) .
From the data obtained on the structure of the tryptic peptides from microcin 7, we propose the following sequence for the native molecule: acetyl-Met-Arg-Thr-GlyAsn-Ala-Asp-X, where X symbolizes an unidentified, acidlabile group that substitutes the terminal aspartic acid. This blocking group is probably small or at least cannot be very hydrophobic, given the chromatographic properties of the native peptide (11) and its tryptic fragments ( Fig. 2 and 3) . We think that this substituent is the reason for the resistance ofthese molecules to carboxypeptidase digestion (see above).
The structure of the unidentified moiety may be related to glycine, since a high amount of that amino acid was found in all the analyses of either the intact microcin or the three tryptic pentapeptides (Table 1) . In our experience, the amount of glycine found is not high enough to imply the presence of two glycine residues per molecule (a possibility also ruled out by the results of the sequencing experiments), but the amount of glycine is higher than expected from a peptide with just one glycine in its structure.
Since all the amino acids in microcin 7, except those located at both ends, are recognized as substrates by proteases considered to be of L specificity, the peptide probably has an all-L configuration, although it should be kept in mind that we have used high enzyme/substrate ratios and long incubation times in those experiments.
The most studied peptide antibiotics are synthesized by nonribosomal mechanisms and they include D amino acids in their structures. Although microcin 7 resembles a short gramicidin (16) , it does not have the configuration or the mechanism of action (see above) of those antibiotics. Our hypothesis is that microcin 7 may be the result of the enzymatic modification of some cellular peptide, perhaps of a cleaved signal peptide, to which it has some resemblance (7) . The relationship between a secreted microbial peptide and signal sequences has been suggested before (10, 27) . This hypothesis of an enzymatic processing of a cellular precursor would also account for the large amount of DNA found to be necessary for the expression of microcin 7 (4) .
Most peptide antibiotics and many colicins disrupt the permeability barrier of the cell membrane, thereby abolishing all macromolecular biosynthesis within seconds. Microcin 7 seems to inhibit only the incorporation of amino acids into proteins (Fig. 7) . The observed stimulation of cell wall synthesis (Fig. 6) agrees with the described effect of inhibitors of protein synthesis on relA strains (14) .
The data so far obtained did not permit us to classify this antibacterial agent, produced by a common resident of the human intestine, either as a bacteriocin or as a peptide antibiotic. Its small size, bacteriostatic mode of action, and production kinetics (11) resemble those of the antibiotics produced by secondary metabolism. However, other properties of microcin 7 resemble the properties of bacteriocins. These properties include the spectrum of antibacterial activity centered on the phylogenetic relatives of the producer strain, composition (L amino acids), and the fact that there exists a specific immunity to this antibacterial agent that is coded for in the same plasmid that codes for the expression g _. 8 . Effect of microcin 7 on leucine uptake by E. coli GS7T1. The cells were grown, harvested, and suspended as described in the text. Fractions (0.4 ml) of the cell suspension were preincubated at 370C in tubes containing either 10 ,ul of sterile water (0) or 0.8 nmol of microcin 7 in 10 ,ul of water (0). After 10 min, 20 ,ug of chloramphenicol was added to each tube, and some of the tube6 also received 0.25 ,umol of sodium arsenate as a positive control (A). After 10 min more, the volume of each tube was adjusted to 0.5 ml with prewarmed medium, and 0.5 ,uCi of ['4C]leucine was added. Samples were taken and processed as described in the text. Each point represents the average of two experiments performed consecutively with the same cell suspension.
of the antibiotic activity (4) . Additional studies on the biosynthetic mechanism involved and the mode of export from the cells to the medium should help to clarify this question.
